Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension

AIM: To investigate the potential effect of inhibitors of phosphodiesterase-5 (PDE-5) for therapy of portal hypertension in liver cirrhosis. METHODS: In the rat model of thioacetamide-induced liver fibrosis/cirrhosis the nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway was investigated....

Descripción completa

Detalles Bibliográficos
Autores principales: Schaffner, Denise, Lazaro, Adhara, Deibert, Peter, Hasselblatt, Peter, Stoll, Patrick, Fauth, Lisa, Baumstark, Manfred W, Merfort, Irmgard, Schmitt-Graeff, Annette, Kreisel, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189851/
https://www.ncbi.nlm.nih.gov/pubmed/30344420
http://dx.doi.org/10.3748/wjg.v24.i38.4356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189851/
https://www.ncbi.nlm.nih.gov/pubmed/30344420
http://dx.doi.org/10.3748/wjg.v24.i38.4356

Ejemplares similares